Author Archive: Daniel Seaton

Daniel Seaton

Daniel Seaton is Manager of Event & Health Communications, working on communications for BIO’s events and health care policy issues. Prior to joining BIO in August 2013, he spent four years in communications at the Pharmaceutical Research and Manufacturers of America. The best part of his job is educating audiences about the many benefits the bioscience industry produces for patients, consumers, and the economy as a whole. Daniel enjoys hiking, camping, and, when he can find a game, playing bridge. Having grown up in New Mexico, one of his favorite foods is roasted green chile. He recently completed a Master’s degree in communications at Georgetown University.

Latest Posts

Morning Consult: Right-Sized Regulations, Innovation and Investor Protection

Jim Greenwood

Today, an op-ed from BIO President and CEO Jim Greenwood appeared in Morning Consult stressing the importance of investor protection by reforming eXtensible Business Reporting Language (XBRL), which is a one-size-fits-all costly reporting requirement that can harm company growth and investor returns. Congressman Robert Hurt (R-VA) introduced a bill – the Small Company Disclosure Simplification Act (H.R. 1965) – that would provide a temporary exemption from XBRL for newly public and low-revenue companies in order Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Innovation Zone Company Snapshots: ONL Therapeutics and Lipella Pharmaceuticals

Innovation-zone-logos-150x150

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Institutes of Health (NIH) and the National Science foundation (NSF) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process prior Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Innovation Zone Company Snapshot: Nanofiber Separations

Innovation-zone-logos-150x150

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Science foundation (NSF) and the National Institutes of Health (NIH) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Jim Greenwood in New York Times: Specialty Tiers Limit Patient Access

Jim Greenwood

Today, the New York Times published a letter from Jim Greenwood, BIO’s President and CEO. Greenwood’s letter discusses the problems that expanded use of specialty tier cost-sharing by the insurance industry are posing for patients, limiting their access to lifesaving therapies and cures. Breakthrough treatments cost billions of dollars, and investors will only take on such risks if they can expect a reasonable return on their investment. The full text of the letter is below: To Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The Power of Innovation

Breast Cancer

Today’s “Fox and Friends” included an informative segment about the staggering advances being made in cancer care thanks to new and forthcoming innovative treatments. The segment featured five doctors from the Sarah Cannon Research Institute, a Nashville-based research organization that partners with biopharmaceutical companies to offer more than 500 clinical trials annually. “Over 40 years since President Nixon declared the War on Cancer, and after decades of giving more drugs and more radiation, we’re now Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,